Shimadzu Fully Automated Sample Preparation Module for LCMS CLAM-2030

Importance of Automated Sample Prep for LCMS

The CLAM-2030 module addresses a critical bottleneck in LC-MS/MS analysis by fully automating sample pretreatment and integration with high-performance mass spectrometers. This innovation enhances data reliability, minimizes human error, and reduces biosafety risks during blood, urine, serum, and plasma processing.

Objectives and Overview

The primary objective is to seamlessly couple sample pretreatment with Shimadzu’s Nexera X2 and LCMS-8060/8050/8045/8040 systems, enabling end-to-end automation from raw biological specimens to quantitative LC-MS/MS data. The module is designed for 24/7 operation and supports on-demand addition or interruption of samples.

Methodology and Instrumentation

The workflow is managed by dedicated control software that:

• Dispenses uncapped blood collection tubes or cups into the carousel.
• Adds internal standards, organic solvents, and reagents.
• Performs protein denaturation, stirring, filtration, optional derivatization, and transfer to the HPLC autosampler.
• Initiates LC-MS/MS measurement on connected triple-quadrupole instruments.

Key hardware includes:

• CLAM-2030 fully automated pretreatment module
• Shimadzu Nexera X2 UHPLC system
• Triple-quad LCMS-8040, LCMS-8045, LCMS-8050 or LCMS-8060 mass spectrometers
• Optional toxicology screening software and forensic databases

Key Results and Discussion

Implementation studies demonstrated:

• Reduction of operator labor time from ~15 minutes manually to ~3 minutes per sample.
• Improved reproducibility of internal standard concentrations by use of septa-equipped vials.
• Enhanced accuracy control with automated flagging of out-of-spec conditions.
• Contained liquid and solid waste within the module to lower infection risk.
• Capability to analyze hundreds of compounds—including drugs of abuse, antibiotics, hormones—in a single run.

Benefits and Practical Applications

By integrating pretreatment and LC-MS/MS analysis, laboratories gain:

• High throughput with continuous operation overnight and on weekends.
• Consistent quantitative data supporting clinical testing, forensic toxicology, and pharmaceutical QA/QC.
• Reduced manual handling errors and biosafety exposure.
• Rapid method deployment through preconfigured software libraries for over 160 toxicological compounds and a spectral database exceeding 2,500 entries.

Future Trends and Applications

Emerging directions include:

• Deep integration with laboratory information systems for automated request loading and result reporting.
• Expansion of compound libraries and AI-driven spectral matching for non-targeted screening.
• Miniaturization of workflows and integration with multi-omics platforms.
• Cloud-based data analytics enabling real-time quality control and remote method optimization.

Conclusion

The CLAM-2030 represents a significant advance in LC-MS/MS workflows, providing fully automated sample pretreatment, robust data quality, and operational efficiency. Its modular design and extensive software support make it well suited for clinical, forensic, and industrial laboratories aiming to streamline high-volume analyses while maintaining stringent quality standards.